Botulinum toxin A - Aquavit Pharmaceuticals/Huons
Alternative Names: aqubotulinumtoxinA - Aquavit Pharmaceuticals/Huons; Clostridium botulinum toxin type A - Huons; Dermatox; DTX-021; HU-014; HU-045; HUTOX; IncobotulinumtoxinA - Hunos; LIZTOXLatest Information Update: 02 Aug 2023
At a glance
- Originator Huons
- Developer Aquavit Pharmaceuticals; Huons
- Class Analgesics; Anti-inflammatories; Antiarrhythmics; Antidepressants; Antimigraines; Antipruritics; Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Eye disorder therapies; Foot disorder therapies; Muscle relaxants; Recombinant proteins; Skin disorder therapies; Urologics; Vascular disorder therapies
- Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Membrane transport protein modulators; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Facial wrinkles; Glabellar lines
- Phase III Hypertrophy; Muscle spasticity